MEMORIAL SLOAN KETTERING CANCER CENTER
Q1 2021 Form 13-F
NEW YORK, NEW YORK
CIK 0001566787
· Institutional investment manager
$162.2M Reported Value Total
Reported value
$162.2M
Quarter over quarter
-15.0%
Holdings
4
Top-10 concentration
100.0%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Kevin Malarkey
Vice President and Controller
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2021 13F record
Q1 2021 13F filing summary
| Period of report | March 31, 2021 |
|---|---|
| Filed | May 17, 2021 |
| Form | 13F-HR |
| Reported value | $162.2M |
| Positions | 4 |
| Change in reported value | -31.3% |
| New positions | 0 |
| Exited positions | 0 |
| Position turnover | 0.0% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2023 13F
Filed Nov 14, 2023
|
3 | $24.6M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
5 | $31.7M |
|
Q1 2023 13F
Filed May 15, 2023
|
5 | $32.6M |
|
Q4 2022 13F
Filed Feb 10, 2023
|
5 | $30.3M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
5 | $29.4M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
5 | $30.3M |
|
Q1 2022 13F
Filed May 16, 2022
|
6 | $86.4M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
6 | $159.1M |
|
Q3 2021 13F
Filed Nov 15, 2021
|
6 | $160.5M |
|
Q2 2021 13F
Filed Aug 16, 2021
|
4 | $153.0M |
|
Q1 2021 13F
Filed May 17, 2021
|
4 | $162.2M |
|
Q4 2020 13F
Filed Feb 16, 2021
|
4 | $236.2M |
Top 4 holdings · Q1 2021
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | RPRX ROYALTY PHARMA PLC | $116.9M | 72.07% |
| 2 | GDX VANECK VECTORS ETF TR | $24.0M | 14.79% |
| 3 | ORIC ORIC PHARMACEUTICALS INC | $14.8M | 9.09% |
| 4 | YMAB Y-MABS THERAPEUTICS INC | $6.6M | 4.04% |
Values as reported on the Q1 2021 Form 13F. Every position is in the holdings table below.